Literature DB >> 8570355

Anxiety in elderly hearing impaired persons.

G Andersson1, M Green.   

Abstract

The association between experiences of hearing impairment and signs of anxiety in 42 elderly hearing impaired patients at a hearing aid centre was investigated. Subjects completed the Hearing Coping Assessment, the Beck Anxiety Inventory, and an audiometric test of hearing. Analysis showed low scores on anxiety and hearing problems compared with other studies. Moreover, scores on anxiety did not correlate with pure tone thresholds for hearing but with self-reported hearing problems (r = .31). Anxiety is important, but it is possible that signs of depression are more strongly related to self-perceived hearing handicap.

Entities:  

Mesh:

Year:  1995        PMID: 8570355     DOI: 10.1177/003151259508100238

Source DB:  PubMed          Journal:  Percept Mot Skills        ISSN: 0031-5125


  5 in total

Review 1.  Optimal management of anxiety in older patients.

Authors:  K J Weiss
Journal:  Drugs Aging       Date:  1996-09       Impact factor: 3.923

2.  Hearing impairment associated with depression in US adults, National Health and Nutrition Examination Survey 2005-2010.

Authors:  Chuan-Ming Li; Xinzhi Zhang; Howard J Hoffman; Mary Frances Cotch; Christa L Themann; M Roy Wilson
Journal:  JAMA Otolaryngol Head Neck Surg       Date:  2014-04       Impact factor: 6.223

3.  Empowering the deaf. Let the deaf be deaf.

Authors:  I M Munoz-Baell; M T Ruiz
Journal:  J Epidemiol Community Health       Date:  2000-01       Impact factor: 3.710

4.  Discrepancy between self-assessed hearing status and measured audiometric evaluation.

Authors:  So Young Kim; Hyung-Jong Kim; Min-Su Kim; Bumjung Park; Jin-Hwan Kim; Hyo Geun Choi
Journal:  PLoS One       Date:  2017-08-08       Impact factor: 3.240

5.  Patient Benefit Following Bimodal CI-provision: Self-reported Abilities vs. Hearing Status.

Authors:  Elisabeth Wallhäusser-Franke; Tobias Balkenhol; Svetlana Hetjens; Nicole Rotter; Jerome J Servais
Journal:  Front Neurol       Date:  2018-09-10       Impact factor: 4.003

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.